Page last updated: 2024-10-31

mitoxantrone and Sterility, Female

mitoxantrone has been researched along with Sterility, Female in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"Improved prognosis in women with multiple sclerosis (MS) undergoing immunosuppressive treatment with mitoxantrone (MITO) has led to an increased interest in the effect of such treatments on fertility."7.74Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. ( Amato, MP; Capra, R; Cocco, E; Gallo, P; Marrosu, MG; Sardu, C; Trojano, M; Uccelli, A, 2008)
"Improved prognosis in women with multiple sclerosis (MS) undergoing immunosuppressive treatment with mitoxantrone (MITO) has led to an increased interest in the effect of such treatments on fertility."3.74Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. ( Amato, MP; Capra, R; Cocco, E; Gallo, P; Marrosu, MG; Sardu, C; Trojano, M; Uccelli, A, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cocco, E1
Sardu, C1
Gallo, P1
Capra, R1
Amato, MP1
Trojano, M1
Uccelli, A1
Marrosu, MG1

Other Studies

1 other study available for mitoxantrone and Sterility, Female

ArticleYear
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2008, Volume: 14, Issue:9

    Topics: Adult; Amenorrhea; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infertility, Female;

2008